within
last
year
protein
microarray
develop
appli
multipl
approach
identif
proteinprotein
interact
proteinsmal
molecul
interact
cancer
profil
detect
microorgan
toxin
identif
antibodi
due
allergen
autoantigen
pathogen
protein
microarray
small
size
typic
microscopi
slide
format
planar
analyt
devic
probe
arrang
high
densiti
provid
abil
screen
sever
hundr
thousand
known
substrat
eg
protein
peptid
antibodi
simultan
due
small
size
minut
amount
spot
probe
analyt
eg
serum
need
particularli
import
featur
limit
expens
review
differ
type
protein
microarray
review
protein
microarray
pma
spot
protein
peptid
antibodi
microarray
ama
spot
antibodi
antibodi
fragment
eg
scfv
revers
phase
protein
microarray
rpma
special
form
pma
crude
protein
mixtur
eg
cell
lysat
fraction
spot
nonprotein
microarray
npma
macromolecul
protein
nucleic
acid
eg
carbohydr
monosaccharid
lipopolysaccharid
spot
studi
exemplari
experi
type
protein
array
discuss
wherev
applic
regard
investig
microorgan
protein
microarray
develop
within
last
year
use
knowledg
technic
innov
develop
dna
microarray
dna
microarray
technolog
evolv
consequ
handl
set
thousand
probe
huge
sequenc
program
begin
microbi
genom
sanger
et
al
fleischmann
et
al
reach
top
mous
human
venter
et
al
genom
technic
aspect
miniatur
tradit
method
westernblot
protein
dot
onto
classic
surfac
nitrocellulos
nylon
membran
could
adapt
protein
microarray
technolog
first
protein
array
construct
highdens
protein
array
analyz
protein
express
cdna
librari
bussow
et
al
array
bear
featur
highdens
spotscm
format
cm
therefor
call
protein
macroarray
way
e
coli
clone
spot
duplic
onto
one
mm
nylon
filter
membran
hybondn
amersham
subsequ
proteinexpress
detect
recombin
express
product
perform
directli
filter
without
purif
develop
highdens
spot
crude
cell
lysat
purifi
protein
spot
onto
pvdf
filter
cut
microscop
slide
format
way
protein
microarray
gener
theoret
densiti
spotscm
studi
detect
limit
could
reach
spot
gapdh
protein
detect
monoclon
antigapdh
antibodi
amolspot
respect
pgspot
luek
et
al
short
time
later
two
public
demonstr
potenti
protein
microarray
screen
whole
proteom
present
first
proteom
wideprotein
array
use
analyz
proteinprotein
interact
saccharomyc
cerevisia
protein
array
consist
yeast
transform
one
clone
orf
fuse
activ
domain
screen
differ
yeast
protein
uetz
et
al
approach
technic
aspect
situ
express
similar
work
bussow
et
al
second
proteom
wide
protein
microarray
consist
uniqu
yeast
protein
modifi
microscop
slide
bear
adject
proteinmicroarray
array
demonstr
usabl
protein
microarray
technolog
screen
proteinprotein
interact
identif
calmodulinand
phospholipidbind
protein
zhu
et
al
exemplari
studi
belong
group
protein
microarray
pma
discuss
repres
pioneer
work
field
protein
microarray
protein
microarray
pma
pma
name
spot
compound
basic
purifi
recombin
protein
peptid
compon
use
broad
rang
applic
discuss
section
common
applic
pma
detect
antibodi
reaction
eg
serum
screen
use
sever
applic
human
bacteri
steller
et
al
plant
protein
kersten
et
al
systemat
search
antibodi
specif
crossreact
done
eleven
polyclon
monoclon
antibodi
pma
contain
yeast
protein
altern
strategi
michaud
et
al
furthermor
pma
use
highthroughput
identif
kinas
target
identifi
eg
potenti
substrat
eg
arabidopsi
thaliana
mitogenactiv
protein
kinas
mpk
purpos
novel
method
allow
high
throughput
studi
protein
phosphoryl
use
microarray
includ
nonredund
arabidopsi
protein
use
thresholdbas
quantif
method
evalu
microarray
result
potenti
substrat
could
identifi
common
kinas
feilner
et
al
polypeptid
protein
domain
gener
complet
protein
spot
well
gener
pma
peptid
microarray
use
detect
molecular
interact
cellular
signal
transduct
stoevesandt
et
al
therefor
phosphoryl
itam
nonphosphoryl
counterpart
itam
peptid
spot
onto
silaniz
glass
surfac
incub
lysat
cell
express
fusion
protein
interact
partner
peptid
microarray
also
use
simultan
detect
pathogen
infect
purpos
peptid
specif
hepat
b
c
virus
human
immunodefici
viru
epstein
barr
viru
syphili
made
function
glyoxyl
group
anchor
glass
surfac
sitespecif
ligat
combin
assay
display
high
sensit
specif
duburcq
et
al
peptid
microarray
perfectli
suit
epitop
map
antibodi
antibodi
fragment
set
peptid
nand
ctermin
truncat
peptid
interest
spot
aldehyd
slide
poetz
et
al
author
introduc
quantifi
spot
perform
rel
affin
rank
recombin
fab
fragment
system
two
spot
requir
one
spot
contain
antigen
captur
molecul
recogn
constant
part
fab
poetz
et
al
affin
valu
calcul
signal
intens
use
ambient
analyt
assay
condit
first
defin
ekin
revers
phase
microarray
rpma
revers
phase
microarray
rpma
special
form
pma
protein
mixtur
deriv
cell
tissu
lysat
spot
approach
offer
possibl
analyz
modifi
protein
obtain
e
coli
yeast
first
rpma
use
quantifi
abund
select
protein
progress
normal
epithelium
prostat
carcinoma
paweletz
et
al
cancer
profil
predomin
applic
rpma
identifi
instanc
potenti
serum
marker
colon
cancer
nam
et
al
studi
fraction
solubil
protein
lovo
colon
cancer
cell
line
array
incub
autoantibodi
patient
subsequ
protein
fraction
select
protein
within
fraction
identifi
ms
analysi
furthermor
rpma
use
simultan
monitor
dynam
sitespecif
phosphoryl
signal
molecul
stimul
jurkat
tcell
chan
et
al
author
determin
dynam
rang
four
order
magnitud
detect
limit
one
protein
lysat
protein
reproduc
protein
quantif
obtain
multipl
replica
dilut
seri
array
mircean
et
al
rpma
analyz
microorgan
publish
rpma
discuss
detail
elsewher
hultschig
et
al
antibodi
microarray
ama
consist
antibodi
antibodi
fragment
use
eg
identif
protein
bacteria
exampl
biotinyl
captur
antibodi
immobil
neutravidinco
slide
incub
solut
contain
toxin
bacteria
detect
subsequ
incub
fluoresc
label
secondari
antibodi
detect
limit
case
test
cholera
toxin
staphylococc
enterotoxin
b
ricin
bacillu
globigii
low
ngml
cfuml
respect
delehanti
ligler
furthermor
ama
use
tool
analyz
protein
content
chang
due
develop
diseas
signal
factor
analysi
perform
ama
consist
differ
antibodi
nitrocelluloseco
glass
slide
probe
protein
extract
mous
embryon
carcinoma
cell
stimul
differenti
protein
identifi
upregul
sensit
ngml
protein
detect
reach
kopf
et
al
differ
studi
antibodi
contain
commerci
microarray
bd
bioscienc
appli
profil
effect
oxldl
oxid
low
densiti
lipoprotein
human
aortic
smooth
muscl
cell
detect
protein
cell
lysat
differenti
express
sukhanov
delafontain
besid
antibodi
antibodi
fragment
scfv
use
gener
ama
howev
although
approach
particularli
interest
bottleneck
analyz
protein
tissu
avail
suitabl
antibodi
overcom
bottleneck
vitro
select
method
phage
display
implement
advanc
effect
vitro
select
scfv
spot
directli
onto
microarray
wingren
et
al
analyz
doublespot
scfv
directli
onto
prior
insolublez
target
protein
angenendt
et
al
besid
protein
nucleic
acid
compon
spot
surfac
bind
protein
microorgan
although
protein
microarray
peluso
et
al
surfac
list
classif
applic
nc
nitrocellulos
super
nitro
telechem
intern
usa
nc
fast
nitrocellulos
coat
fast
slide
schleicher
schuell
germani
ps
polystyrol
pma
protein
microarray
ama
antibodi
microarray
rpma
revers
phase
protein
microarray
npma
nonprotein
microarray
nappa
nucleic
acid
programm
protein
array
nevertheless
present
similar
applic
possibl
first
exampl
npma
contain
carbohydr
subsequ
probe
differ
e
coli
strain
e
coli
cell
bound
adhes
mannos
spot
microarray
advantag
approach
nondestruct
natur
techniqu
microorgan
could
recov
use
investig
eg
antibacteri
suscept
substrat
acquisit
test
studi
bacteria
stain
use
nucleic
acid
dye
routin
e
coli
cell
use
detect
limit
observ
cell
disney
seeberg
anoth
exampl
npma
monosaccharid
array
detect
bacteri
toxin
array
nacetyl
galactosamin
galnac
nacetylneuramin
acid
deriv
immobil
surfac
use
receptor
bacteri
toxin
cholera
tetanu
bound
specif
monosaccharid
wherea
label
cell
e
coli
salmonella
typhimurium
listeria
monocytogen
staphylococc
enterotoxin
b
bound
toxin
limit
detect
around
ngml
ngundi
et
al
anoth
experi
lipopolysaccharid
lp
microarray
use
detect
antibodi
thirumalapura
et
al
therefor
lp
isol
differ
bacteria
immobil
nitrocelluloseco
glass
slide
specif
lp
array
test
use
four
monoclon
antibodi
bacteria
detect
limit
antibodi
ngml
besid
obviou
advantag
protein
microarray
highthroughput
highdens
improv
reproduc
low
sampl
consumpt
also
limit
bottleneck
part
review
discuss
gener
aspect
applic
protein
microarray
demand
avail
purifi
protein
case
hundr
thousand
protein
spot
major
limit
fascin
approach
circumv
limit
done
ramachandran
et
al
gener
protein
microarray
print
cdna
onto
glass
slide
besid
captur
antibodi
antigst
ad
cellfre
express
system
protein
gener
directli
microarray
bound
fuse
gstpart
captur
antibodi
protein
could
analyz
convent
proteinmicroarray
demonstr
feasibl
specif
antibodi
bind
distinct
fusion
protein
map
pairwis
interact
among
human
dna
replic
protein
ramachandran
et
al
circumv
purif
might
use
applic
spot
unpurifi
protein
possibl
recent
approach
cellulos
surfac
use
protein
bound
indirectli
via
cellulos
bind
protein
ofir
et
al
possibl
circumv
limit
avail
purifi
andor
modifi
protein
rpma
approach
present
protein
due
composit
mani
differ
amino
acid
class
heterogen
macromolecul
variabl
properti
make
extrem
complic
find
common
surfac
suitabl
differ
protein
broad
rang
molecular
weight
physicochem
properti
charg
hydrophob
therefor
multipl
surfac
develop
last
year
list
tabl
applic
therebi
import
bind
due
coval
bind
physic
adsorpt
bind
could
chemic
reaction
physic
adsorpt
directli
surfac
structur
spot
molecul
proteinantibodi
indirectli
linker
molecul
linker
molecul
part
protein
fusion
protein
separ
molecul
find
surfac
suitabl
spot
compon
project
major
challeng
one
recommend
use
distinct
surfac
public
deal
aspect
global
investig
driven
discret
scientif
problem
problemoptim
condit
special
approach
found
obtain
result
reason
avail
data
often
conferr
differ
spot
materi
eg
differ
protein
analyt
divers
sera
protein
spot
differ
surfac
process
differ
condit
howev
systemat
studi
find
optim
process
condit
suitabl
surfac
angenendt
et
al
angenendt
et
al
gutmann
et
al
often
without
studydriven
relev
aspect
orient
spot
compound
applic
suffici
amount
reactiv
part
eg
antigen
epitop
protein
surfac
spot
microorgan
present
aspect
less
relev
other
like
quantit
analysi
enzymat
reaction
interact
studi
phosphoryl
protein
drug
screen
becom
essenti
relev
reactiv
site
protein
usual
limit
effect
randomli
vs
specif
orient
captur
agent
base
fullsiz
antibodi
fab
fragment
two
type
streptavidinco
slide
studi
peluso
et
al
orient
captur
agent
increas
analytebind
capac
use
surfac
plasmon
reson
analysi
dens
monolay
activ
fab
fragment
detect
peluso
et
al
aspect
also
studi
enzymat
activ
activ
complet
lost
lower
cha
et
al
differ
approach
link
protein
dnacoat
array
mediat
pcramplifi
dna
dna
bind
domain
new
method
stabl
bind
protein
surfac
recent
develop
link
protein
via
leucin
zipper
therefor
elastin
mimet
domain
coval
bound
octyltrichlorosilan
surfac
photoreact
amino
acid
uv
irradi
wherea
target
protein
fuse
complementari
leucin
zipper
helix
strong
noncoval
bind
helic
lead
effect
immobil
target
protein
sensit
specif
also
import
featur
link
paramet
like
signal
nois
ratio
background
bind
serum
protein
background
paramet
influenc
surfac
process
detect
also
affect
detect
limit
good
way
measur
paramet
case
valu
certain
coupl
action
partner
eg
proteinantibodi
often
detect
individu
experiment
setup
convent
detect
method
microarray
often
use
fluoresc
dye
detect
irradi
laser
scanner
detect
method
discuss
intens
elsewher
espina
et
al
feilner
et
al
studi
new
approach
point
reach
much
higher
sensit
special
method
call
mist
multipl
spot
techniqu
angenendt
et
al
b
multipl
spot
step
perform
success
one
posit
experi
protein
spot
first
spot
round
wash
block
step
correspond
antibodi
spot
second
spot
round
posit
techniqu
possibl
perform
enzymat
reaction
reach
approach
extrem
high
sensit
ymol
mol
chemic
reaction
take
place
small
reaction
compart
form
droplet
normal
enzymat
reaction
produc
solubl
product
possibl
convent
protein
microarray
product
could
mix
planar
surfac
technic
approach
better
sensit
roll
circl
amplif
rca
lizardi
et
al
system
requir
direct
conjug
protein
analyz
label
eg
biotin
digoxigenin
label
detect
antibodi
bound
primer
hybrid
circular
dna
molecul
primer
extend
polymeras
detect
fluoresc
label
oligonucleotid
complementari
elong
dna
use
ama
consist
distinct
antibodi
specif
serum
protein
use
detect
via
rca
protein
express
profil
lung
cancer
patient
gao
et
al
b
c
e
fig
possibl
identif
microorgan
microorgan
dark
blue
symbol
fix
directli
coat
microarray
possibl
speciesspecif
monosaccharid
light
green
b
altern
microorgan
bound
via
speciesspecif
antibodi
black
ys
ce
direct
detect
speciesspecif
label
antibodi
black
ys
c
sandwich
assay
speciesspecif
antibodi
black
ys
secondari
label
antibodi
brown
ys
red
green
star
b
could
perform
mist
technolog
angenendt
et
al
b
detect
could
perform
use
antibodi
bound
enzym
blue
circl
bound
ys
activ
convert
substrat
yellow
detect
product
green
red
circl
e
import
use
eg
diagnosi
stabil
diagnost
protein
microarray
test
system
two
kind
stabil
distinguish
one
stabil
surfac
stabil
spot
protein
stabil
analysi
differ
antibodi
spot
four
differ
surfac
store
two
differ
condit
dri
block
solut
week
without
crucial
differ
angenendt
et
al
shelf
life
detect
year
rheumachip
differ
autoantigen
suitabl
simultan
determin
signific
autoantibodi
associ
rheumat
diseas
schultepelkum
et
al
protein
microarray
multipl
sever
thousand
spot
compound
analyz
applic
one
singl
analyt
mixtur
one
time
multiplex
approach
multipl
analyt
also
investig
time
multiplex
aspect
import
approach
approach
mani
probe
screen
eg
medic
routin
diagnosi
becom
tremend
import
recent
aspect
multiplex
discuss
detail
point
two
major
strategi
one
multiplex
differ
fluorophor
approach
enabl
multiplex
limit
detect
label
microarray
approach
could
perform
better
nonarray
system
like
liquichip
system
qiagen
second
approach
perform
multiplex
compartment
physic
compart
multiwel
slide
differ
manufactur
nonphys
compartment
mist
angenendt
et
al
angenendt
et
al
b
besid
gener
applic
protein
microarray
mention
public
deal
microorgan
section
exemplari
public
field
microbiolog
present
deal
protein
microarray
possibl
detect
method
summar
fig
first
pma
use
serodiagnosi
infecti
diseas
contain
dilut
row
human
igg
pg
igm
pg
antigen
pg
toxoplasma
gondii
rubella
viru
cytomegaloviru
herp
simplex
viru
type
ii
spot
aminosilaneactiv
glass
slide
mezzasoma
et
al
analysi
show
linear
detect
intern
calibr
curv
igg
igm
antigen
respect
result
similar
elisa
analysi
group
perform
serumscreen
experi
serum
probe
mening
patient
pma
differ
recombin
neisseria
protein
protein
code
phase
variabl
gene
show
immun
respons
least
one
patient
sera
nine
protein
elicit
immun
respons
three
patient
phasevari
opac
protein
opav
show
respons
patient
sera
also
interest
aspect
protein
annot
hypothet
protein
authent
frameshift
neisseria
genom
protein
microarray
technolog
could
use
verifi
predict
genom
data
steller
et
al
anoth
bacteri
pma
contain
yersinia
pesti
protein
use
profil
antibodi
respons
immun
rabbit
studi
antibodi
protein
could
detect
protein
v
antigen
predomin
antibodi
respons
occur
identifi
target
could
use
evalu
candid
vaccin
diagnost
marker
pma
serum
screen
bacteri
protein
establish
shown
use
viral
protein
instead
bacteri
protein
technic
differ
could
use
identif
classif
virus
recent
pma
use
investig
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
import
step
develop
vaccin
diagnost
marker
profil
antibodi
individu
protein
studi
recombin
protein
associ
structur
put
uncharacter
protein
sarscov
prepar
use
gener
sarscov
pma
subsequ
screen
sar
patient
sera
igg
antibodi
antibodi
reaction
protein
could
observ
found
one
immunogen
protein
good
vaccin
candid
moreov
identifi
potenti
diagnost
marker
could
support
hypothesi
protein
synthes
viru
cycl
deduc
presenc
antibodi
pmanpma
array
consist
differ
mycobacterium
tuberculosi
antigen
use
serolog
tuberculosi
tb
assay
tong
et
al
array
consist
recombin
antigen
purifi
polysaccharid
lipopolysaccharid
oligosaccharid
bound
bovin
serum
albumin
antigen
fraction
tuberculosi
cell
cultur
fluid
spot
epoxyco
slide
array
could
store
week
one
antigen
discrimin
well
tb
nontb
wherea
antigen
gave
poor
discrimin
due
e
coli
protein
contamin
lack
glycosyl
e
coli
review
protein
microarray
technolog
present
begin
recent
applic
protein
microarray
divid
major
group
pma
rpma
ama
npma
approach
limit
protein
microarray
technolog
possibl
solut
discuss
use
protein
microarray
studi
microorgan
point
limit
advanc
identif
microorgan
use
protein
microarray
major
limit
high
detect
limit
could
reach
new
technolog
advanc
fortun
encourag
approach
indirect
identif
pathogen
interact
identifi
serum
antibodi
matter
time
protein
microarray
especi
antibodymicroarray
use
identif
done
first
vitro
model
import
identif
pathogen
medic
sampl
eg
stool
blood
bodi
fluid
environment
sourc
eg
soil
air
filtrat
two
field
benefit
address
problem
person
medicin
well
aspect
come
bioterror
one
could
expect
near
futur
protein
microarray
establish
mani
applic
microbiolog
investig
